Lupin informs about press release

15 Sep 2021 Evaluate

Lupin has informed that it attached a press release as regards launch of the authorized generic version of Duexis® (ibuprofen and famotidine) Tablets, 800 mg/ 26.6 mg, of Horizon Medicines LLC. Considered this as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

1630.75 1.55 (0.10%)
10-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1510.00
Dr. Reddys Lab 6089.30
Cipla 1533.80
Zydus Lifesciences 1082.55
Lupin 1630.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.